{
    "fund_name": "WisdomTree BioRevolution UCITS ETF - USD Acc",
    "isin": "IE000O8KMPM1",
    "type": "ETF",
    "ucits": true,
    "replication_method": "physical",
    "leverage": false,
    "derivatives": false,
    "swaps": false,
    "inverse": false,
    "complex_factors": [
        "Complex thematic index focusing on BioRevolution activities",
        "Potential for concentrated sector/geographic risk",
        "ESG screening criteria may add complexity to selection process"
    ],
    "classification": "non-complex",
    "supporting_data": "The ETF uses physical replication to track the WisdomTree BioRevolution ESG Screened Index, which focuses on companies involved in biotechnology and genetic advancements. While the thematic focus and ESG screening may add some complexity to the selection process, the fund does not use derivatives, leverage, or synthetic replication methods. The risk profile is rated 6/7, which is relatively high but not unusual for equity-focused ETFs. The fund's primary complexity factors stem from the specialized nature of its index rather than structural complexity. The use of derivatives is limited to efficient portfolio management (repurchase/reverse repurchase agreements and stock lending), which does not trigger MiFID II complexity classification. The fund is UCITS-compliant and follows standard ETF practices, making it suitable for retail investors.",
    "confidence": 90
}